Skip to main content
. 2017 Jan 26;23(3):453–460. doi: 10.1097/MIB.0000000000001021

FIGURE 1.

FIGURE 1.

Flow diagram. Patient enrollment in the IMAgINE 1 and 2 studies as of January 31, 2015, data cutoff. ADA, adalimumab. aPatients may have had more than one reason for discontinuation.